HUT58519A - Process for producing pharmaceutical composition suitable for treating alzheimer disease - Google Patents

Process for producing pharmaceutical composition suitable for treating alzheimer disease

Info

Publication number
HUT58519A
HUT58519A HU904191A HU419190A HUT58519A HU T58519 A HUT58519 A HU T58519A HU 904191 A HU904191 A HU 904191A HU 419190 A HU419190 A HU 419190A HU T58519 A HUT58519 A HU T58519A
Authority
HU
Hungary
Prior art keywords
pharmaceutical composition
composition suitable
alzheimer disease
treating alzheimer
producing pharmaceutical
Prior art date
Application number
HU904191A
Other languages
Hungarian (hu)
Other versions
HU904191D0 (en
HU207444B (en
Inventor
E Szilveszter Vizi
Jenoe Szilbereky
Nagy Peter Literati
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Priority to HU904191A priority Critical patent/HU207444B/en
Publication of HU904191D0 publication Critical patent/HU904191D0/en
Priority to IE243191A priority patent/IE912431A1/en
Priority to AU82053/91A priority patent/AU645826B2/en
Priority to PCT/HU1991/000033 priority patent/WO1992000737A1/en
Priority to JP91512036A priority patent/JPH05508843A/en
Priority to EP91912875A priority patent/EP0607125A1/en
Priority to ZA915462A priority patent/ZA915462B/en
Priority to CS912165A priority patent/CZ280474B6/en
Publication of HUT58519A publication Critical patent/HUT58519A/en
Priority to NO93930083A priority patent/NO930083L/en
Publication of HU207444B publication Critical patent/HU207444B/en
Priority to HU9500118P priority patent/HU211340A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
HU904191A 1990-07-12 1990-07-12 Method for producing therapeutical preparation suitable for treating alzheimer-disease HU207444B (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
HU904191A HU207444B (en) 1990-07-12 1990-07-12 Method for producing therapeutical preparation suitable for treating alzheimer-disease
EP91912875A EP0607125A1 (en) 1990-07-12 1991-07-11 Composition for the treatment of alzheimer's disease and process for preparing the same
JP91512036A JPH05508843A (en) 1990-07-12 1991-07-11 Compositions for the treatment of Alzheimer's disease and methods for preparing the same
AU82053/91A AU645826B2 (en) 1990-07-12 1991-07-11 Composition for the treatment of alzheimer's disease and process for preparing the same
PCT/HU1991/000033 WO1992000737A1 (en) 1990-07-12 1991-07-11 Composition for the treatment of alzheimer's disease and process for preparing the same
IE243191A IE912431A1 (en) 1990-07-12 1991-07-11 Composition for the treatment of alzheimer's disease and¹process for preparing the same
ZA915462A ZA915462B (en) 1990-07-12 1991-07-12 Composition for the treatment of alzheimer's disease and process for preparing the same
CS912165A CZ280474B6 (en) 1990-07-12 1991-07-12 Preparation for treating alzheimer's disease and process for preparing thereof
NO93930083A NO930083L (en) 1990-07-12 1993-01-11 COMPOSITION FOR TREATING ALZHEIMER'S DISEASE AND PROCEDURE FOR PRODUCING SAME
HU9500118P HU211340A9 (en) 1990-07-12 1995-05-03 Composition for the treatment of alzheimer s disease and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU904191A HU207444B (en) 1990-07-12 1990-07-12 Method for producing therapeutical preparation suitable for treating alzheimer-disease

Publications (3)

Publication Number Publication Date
HU904191D0 HU904191D0 (en) 1990-12-28
HUT58519A true HUT58519A (en) 1992-03-30
HU207444B HU207444B (en) 1993-04-28

Family

ID=10967276

Family Applications (1)

Application Number Title Priority Date Filing Date
HU904191A HU207444B (en) 1990-07-12 1990-07-12 Method for producing therapeutical preparation suitable for treating alzheimer-disease

Country Status (8)

Country Link
EP (1) EP0607125A1 (en)
JP (1) JPH05508843A (en)
AU (1) AU645826B2 (en)
CZ (1) CZ280474B6 (en)
HU (1) HU207444B (en)
IE (1) IE912431A1 (en)
WO (1) WO1992000737A1 (en)
ZA (1) ZA915462B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730463B1 (en) * 1993-11-26 2000-02-02 Karla Lehmann Use of lithium compounds in the treatment and prevention of alzheimer's disease
KR20010034588A (en) 1998-03-11 2001-04-25 피터 기딩스 Composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment

Also Published As

Publication number Publication date
CS216591A3 (en) 1992-04-15
IE912431A1 (en) 1992-01-15
CZ280474B6 (en) 1996-01-17
AU8205391A (en) 1992-02-04
WO1992000737A1 (en) 1992-01-23
HU904191D0 (en) 1990-12-28
EP0607125A1 (en) 1994-07-27
ZA915462B (en) 1992-04-29
JPH05508843A (en) 1993-12-09
AU645826B2 (en) 1994-01-27
HU207444B (en) 1993-04-28

Similar Documents

Publication Publication Date Title
HUT61664A (en) Process for producing pharmaceutical composition for treating malaria
HUT61600A (en) Process for producing l-triptophane
HUT62804A (en) Process for producing synergetic medicinal dosage form
HUT54046A (en) Process for producing pharmaceutical compositions
HUT61661A (en) Process for producing pharmaceutical compositions for treating inflammatory gastrointestinal diseases
HUT53655A (en) Process for producing pharmaceutical compositions suitable for treating hiv-infected patients
HUT59725A (en) Process for producing human rutenleukine-5-receptor
HUT62193A (en) Process for producing pharmaceutical composition improving the effect of photoageing
HUT59819A (en) Process for producing stabilized pharmaceutical compositions
HU910840D0 (en) Process for producing human ciliary neuronotrophic factor
HUT61201A (en) Process for producing pharmaceutical compositions suitable for treating dermatitis
HUT61548A (en) Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds
HUT58785A (en) Process for producing hypoallergene moth-oils
HUT62472A (en) Process for producing locqlly applicable pharmaceutically compositions
HUT57051A (en) Pharmaceutical composition for treating tonsilitis and process for producing them
HUT58699A (en) Process for producing 2-chloro-5-methyl-pyridine
HUT58519A (en) Process for producing pharmaceutical composition suitable for treating alzheimer disease
HUT58522A (en) Process for producing pharmaceutical compositions suitable for treating allergic conjunctivitis
HU907129D0 (en) Process for producing pharmaceutical preparatives
HUT59601A (en) Process for producing hard capsule composition
HUT55636A (en) Process for producing pharmaceutical composition
HU9202920D0 (en) Process for producing 1-hydroxyalkyl-5-nitroimidazoles
HUT60239A (en) Process for producing glian
HU910745D0 (en) Process for producing 1-treonine
HU910578D0 (en) Process for producing 4-hydroxiphenethyl-alcohol

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: BIOREX KUTATO ES FEJLESZTOE RT., HU

GB9A Succession in title

Owner name: CYTRX CORPORATION, US

Free format text: FORMER OWNER(S): BIOREX KUTATO ES FEJLESZTOE RT., HU; BIOREX KUTATO ES FEJLESZTOE RT., HU; BIOREX KUTATO-FEJLESZTOE KFT., HU